Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …

As the number of individuals vaccinated against SARS-CoV-2 rises worldwide, population-
level data regarding the vaccines' ability to reduce infection are being generated …

While blood antibodies mediate protective immunity in most organs, whether they protect
nasal surfaces in the upper airway is unclear. Using multiple viral infection models in mice …

Abstract mRNA vaccines for SARS-CoV-2 have shown exceptional clinical efficacy,
providing robust protection against severe disease. However, our understanding of …

In early 2020, a global emergency was upon us in the form of the coronavirus disease 2019
(COVID‐19) pandemic. While horrific in its health, social and economic devastation, one …

In view of the scarcity of data to guide decision making, we evaluated how BNT162b2 and
mRNA-1273 vaccines affect the immune response in lactating women and the protective …

Prioritizing Ontario's long-term care home (LTCH) residents for vaccination against severe
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …

Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …

Mucosal immune responses are critical to prevent respiratory infections but it is unclear to
what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA …

Background Few studies have directly compared virus-specific antibodies and their
neutralizing capacity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV …